Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-010747)

Filing Details

Accession Number:: 0001127602-12-010747
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-03-15 15:21:49
Reporting Period:: 2012-03-13

Filing Date:: 2012-03-15
Accepted Time:: 2012-03-15 15:21:49
Original Submission Date:: 2012-03-15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882796	Biocryst Pharmaceuticals Inc	BCRX	Biological Products, (No Disgnostic Substances) (2836)	621413174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1022936	A Charles Sanders	4505 Emperor Blvd. Suite 200 Durham NC 27703		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-13	2,000	$5.20	7,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.19 to $5.24. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.